Published 2020
| Version v1
Publication
Soluble CD163 and mannose receptor as markers of liver disease severity and prognosis in patients with primary biliary cholangitis
- Creators
- Bossen, Lars
- Rebora, Paola
- Bernuzzi, Francesca
- Jepsen, Peter
- Gerussi, Alessio
- Andreone, Pietro
- Galli, Andrea
- Terziroli, Benedetta
- Alvaro, Domenico
- Labbadia, Giancarlo
- Aloise, Chiara
- Baiocchi, Leonardo
- Giannini, Edoardo
- Abenavoli, Ludovico
- Toniutto, Pierluigi
- Marra, Fabio
- Marzioni, Marco
- Niro, Grazia
- Floreani, Annarosa
- Møller, Holger Jon
- Valsecchi, Maria Grazia
- Carbone, Marco
- Grønbaek, Henning
- Invernizzi, Pietro
- Others:
- Bossen, Lar
- Rebora, Paola
- Bernuzzi, Francesca
- Jepsen, Peter
- Gerussi, Alessio
- Andreone, Pietro
- Galli, Andrea
- Terziroli, Benedetta
- Alvaro, Domenico
- Labbadia, Giancarlo
- Aloise, Chiara
- Baiocchi, Leonardo
- Giannini, Edoardo
- Abenavoli, Ludovico
- Toniutto, Pierluigi
- Marra, Fabio
- Marzioni, Marco
- Niro, Grazia
- Floreani, Annarosa
- Møller, Holger Jon
- Valsecchi, Maria Grazia
- Carbone, Marco
- Grønbaek, Henning
- Invernizzi, Pietro
Description
In primary biliary cholangitis (PBC) macrophages are involved in liver inflammation and fibrosis. The macrophage activation markers, soluble (s)CD163 and mannose receptor (sMR) are associated with liver disease severity and prognosis in other chronic liver diseases. We aimed to investigate sCD163 and sMR in PBC patients.
Additional details
- URL
- http://hdl.handle.net/11567/1005883
- URN
- urn:oai:iris.unige.it:11567/1005883
- Origin repository
- UNIGE